Journey Medical (DERM) Non-Current Assets (2020 - 2026)

Journey Medical's Non-Current Assets history runs 7 years deep, the most recent figure standing at $26.6 million for Q1 2026.

• Quarterly Non-Current Assets fell 14.23% year-over-year to $26.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113.0 million (up 13.39% YoY) and the FY2025 annual result came in at $27.7 million, down 13.55% from the prior year.
• Non-Current Assets was $26.6 million for Q1 2026 at Journey Medical, down from $27.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $35.1 million in Q1 2023 and bottomed at $17.9 million in Q3 2024.
• A 5-year average of $26.3 million and a median of $27.7 million in 2025 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 114.85% — and 2024, when it tumbled 44.33%.
• Journey Medical's Non-Current Assets stood at $27.5 million in 2022, then dropped by 25.79% to $20.4 million in 2023, then soared by 57.21% to $32.1 million in 2024, then slipped by 13.55% to $27.7 million in 2025, then fell by 4.15% to $26.6 million in 2026.
• Business Quant data shows DERM's Non-Current Assets at $26.6 million in Q1 2026, $27.7 million in Q4 2025, and $28.8 million in Q3 2025.